Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Hoya Technosurgical Corporation currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners, indicating a focused but divided prosecution effort. Despite the examiners involved, the portfolio is concentrated within 1 distinct art unit, which suggests a consistent technical focus for their patent applications. This concentration in 1 distinct art unit may allow for a more predictable prosecution strategy even as different examiners review the files.
The busiest examiner for the company is GURTOWSKI, RICHARD C, who is responsible for 1 pending office action. This distribution shows that no examiner holds a majority of the pending workload, as the 2 pending office actions are split among the 2 distinct examiners. Practitioners should note that while the Biotechnology & Pharmaceuticals area often involves complex examination, the current workload is limited to 2 pending office actions. The presence of GURTOWSKI, RICHARD C as the busiest examiner with only 1 pending office action highlights the decentralized nature of the examiner assignments for this specific portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GURTOWSKI, RICHARD C | 1 | 72.3% | +37.7% |
| WANG, RUIXUE | 1 | 57.4% | +17.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18008526 | VIRUS PURIFICATION METHOD USING APATITE COLUMN | WANG, RUIXUE | 12d |
| 18843105 | ADSORPTION APPARATUS AND METHOD OF MANUFACTURING ADSORPTION APPARATUS | GURTOWSKI, RICHARD C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18008526 | VIRUS PURIFICATION METHOD USING APATITE COLUMN | WANG, RUIXUE | 12d |
| 18843105 | ADSORPTION APPARATUS AND METHOD OF MANUFACTURING ADSORPTION APPARATUS | GURTOWSKI, RICHARD C | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18843105 | ADSORPTION APPARATUS AND METHOD OF MANUFACTURING ADSORPTION APPARATUS | GURTOWSKI, RICHARD C | — | §102§103§112 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18008526 | VIRUS PURIFICATION METHOD USING APATITE COLUMN | WANG, RUIXUE | 1672 | §102§103§112 | Final Rejection | 12d | Pending | Dec 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial